Quanta BioDesign Ltd

Quanta BioDesign, Ltd. is a privately held company located in Plain City, Ohio. Founded with a focus on scientific innovation, Quanta BioDesign employs 15 individuals and generates approximately $5 million in annual revenue. Quanta BioDesign specializes in developing and commercializing products for companies engaged in drug discovery and diagnostic development. Their core offering revolves around proprietary discrete polyethylene glycol (dPEG®) chemistries, encompassing processes for creating these compounds. Their single molecular weight ethylene glycol conjugation technology, dPEG®, addresses challenges commonly encountered in developing diagnostics and therapeutics, such as aggregation, non-specific interactions, solubility issues, delivery difficulties, short serum half-life, toxicity, and antigenicity. Quanta BioDesign's dPEG® product line is customizable to meet specific requirements across diverse diagnostic and therapeutic applications. The company actively develops new cross-linking and labeling chemistries integrating dPEG® technology, aiming to advance therapeutic and diagnostic development. For company updates, product announcements, and discussions on applications of dPEG® products, visit their LinkedIn page.